Clinical Trials Insight: 700012951
Latest Information Update: 23 Aug 2006
At a glance
- Drugs Vapendavir (Primary)
- Indications Rhinovirus infections
- Focus Adverse reactions
- Sponsors Biota Pharmaceuticals
- 23 Aug 2006 Status change
- 21 Apr 2006 New trial record.